Showing 1 - 13 results of 13 for search 'Steven J. Drews', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron by Sheila F. O’Brien, Niamh Caffrey, Qi-Long Yi, Chantale Pambrun, Steven J. Drews
Published 2022-10-01
Article -
5
Self-collected mid-turbinate swabs for the detection of respiratory viruses in adults with acute respiratory illnesses. by Oscar E Larios, Brenda L Coleman, Steven J Drews, Tony Mazzulli, Bjug Borgundvaag, Karen Green, STOP-Flu Study Group, Allison J McGeer
Published 2011-01-01
Article -
6
Hepatitis B Blood Donor Screening Data: An Under-Recognized Resource for Canadian Public Health Surveillance by Sheila F. O’Brien, Cassandra N. Reedman, Carla Osiowy, Shelly Bolotin, Qi-Long Yi, Lillian Lourenço, Antoine Lewin, Mawuena Binka, Niamh Caffrey, Steven J. Drews
Published 2023-02-01
Article -
7
A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to... by Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne-Claude Gingras, Ashleigh Tuite, Ninette F. Robbins, Guillermo Orjuela, Craig Jenkins, Valerie Conrod, Qi-Long Yi, Sheila F. O’Brien, Steven J. Drews
Published 2022-06-01
Article -
8
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021 by Yi-Chan J. Lin, David H. Evans, Ninette F. Robbins, Guillermo Orjuela, Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne-Claude Gingras, Ashleigh Tuite, Qi-Long Yi, Sheila F. O’Brien, Steven J. Drews
Published 2023-08-01
Article -
9
Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health by Sheila F. O’Brien, Niamh Caffrey, Qi-Long Yi, Shelly Bolotin, Naveed Z. Janjua, Mawuena Binka, Caroline Quach Thanh, Derek R. Stein, Amanda Lang, Amy Colquhoun, Chantale Pambrun, Cassandra N. Reedman, Steven J. Drews
Published 2023-02-01
Article -
10
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals by Brian Grunau, Martin Prusinkiewicz, Michael Asamoah-Boaheng, Liam Golding, Pascal M. Lavoie, Martin Petric, Paul N. Levett, Scott Haig, Vilte Barakauskas, Mohammad Ehsanul Karim, Agatha N. Jassem, Steven J. Drews, Sadaf Sediqi, David M. Goldfarb
Published 2022-10-01
Article -
11
Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273 by Brian Grunau, Liam Golding, Martin A. Prusinkiewicz, Michael Asamoah-Boaheng, Richard Armour, Ana Citlali Marquez, Agatha N. Jassem, Vilte Barakauskas, Sheila F. O’Brien, Steven J. Drews, Scott Haig, Pascal M. Lavoie, David M. Goldfarb
Published 2022-04-01
Article -
12
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses by Yi-Chan J. Lin, David H. Evans, Ninette F. Robbins, Guillermo Orjuela, Queenie Hu, Reuben Samson, Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne-Claude Gingras, Ashleigh Tuite, Qi-Long Yi, Sheila F. O’Brien, Steven J. Drews
Published 2022-10-01
Article -
13
How well do ICD-9 physician claim diagnostic codes identify confirmed pertussis cases in Alberta, Canada? A Canadian Immunization Research Network (CIRN) Study by Sumana Fathima, Kimberley A. Simmonds, Steven J. Drews, Lawrence W. Svenson, Jeffrey C. Kwong, Salaheddin M. Mahmud, Susan Quach, Caitlin Johnson, Kevin L. Schwartz, Natasha S. Crowcroft, Margaret L. Russell, For the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network Vaccine Effectiveness Working Group
Published 2017-07-01
Article